Access the full text.
Sign up today, get DeepDyve free for 14 days.
J. Kpodonu, M. Massad, R. Chaer, Amitra Caines, Alexander Evans, N. Snow, A. Geha (2005)
The US experience with lung transplantation for pulmonary lymphangioleiomyomatosis.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 24 9
E. Radzikowska (2015)
Lymphangioleiomyomatosis: New Treatment PerspectivesLung, 193
T. Machuca, M. Losso, S. Camargo, S. Schio, I. Melo, B. Hochhegger, J. Felicetti, J. Camargo (2011)
Lung transplantation for lymphangioleiomyomatosis: single-center Brazilian experience with no chylothorax.Transplantation proceedings, 43 1
Edinburgh Research Explorer Characterisation of CDKL5 Transcript Isoforms in Human and Mouse
K. Ando, M. Kurihara, H. Kataoka, M. Ueyama, S. Togo, Teruhiko Sato, T. Doi, S. Iwakami, Kazuhisa Takahashi, K. Seyama, M. Mikami (2013)
Efficacy and safety of low-dose sirolimus for treatment of lymphangioleiomyomatosis.Respiratory investigation, 51 3
G. Thabut, J. Christie, P. Ravaud, Y. Castier, Galle Dauriat, G. Jébrak, M. Fournier, Guy Lesche, R. Porcher, H. Mal (2009)
Survival After Bilateral Versus Single-Lung Transplantation for Idiopathic Pulmonary FibrosisAnnals of Internal Medicine, 151
R. Yusen, L. Edwards, A. Kucheryavaya, C. Benden, A. Dipchand, S. Goldfarb, B. Levvey, L. Lund, B. Meiser, J. Rossano, J. Stehlik (2015)
The Registry of the International Society for Heart and Lung Transplantation: Thirty-second Official Adult Lung and Heart-Lung Transplantation Report--2015; Focus Theme: Early Graft Failure.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 34 10
A. Boehler, Rudolf Speich, Erich Russi, Walter Weder (1996)
Lung transplantation for lymphangioleiomyomatosis.The New England journal of medicine, 335 17
M. King-Biggs, J. Dunitz, Soon Park, S. Savik, M. Hertz (2003)
Airway anastomotic dehiscence associated with use of sirolimus immediately after lung transplantationTransplantation, 75
S. Harari, D. Elia, O. Torre, E. Bulgheroni, E. Provasi, J. Moss (2016)
Sirolimus Therapy for Patients With Lymphangioleiomyomatosis Leads to Loss of Chylous Ascites and Circulating LAM Cells.Chest, 150 2
T. Oto, Y. Okada, T. Bando, M. Minami, T. Shiraishi, T. Nagayasu, M. Chida, M. Okumura, H. Date, S. Miyoshi, T. Kondo, The Transplantation (2009)
Registry of the Japanese society of lung and heart–lung transplantation: the official Japanese lung transplantation report 2012General Thoracic and Cardiovascular Surgery, 61
T. Ohara, T. Oto, K. Miyoshi, H. Tao, M. Yamane, S. Toyooka, M. Okazaki, H. Date, Y. Sano (2008)
Sirolimus ameliorated post lung transplant chylothorax in lymphangioleiomyomatosis.The Annals of thoracic surgery, 86 6
M. Reynaud‐Gaubert, J. Mornex, H. Mal, M. Treilhaud, C. Dromer, S. Quêtant, F. Leroy-Ladurie, R. Guillemain, F. Philit, G. Dauriat, D. Grenet, M. Stern (2008)
Lung Transplantation for Lymphangioleiomyomatosis: The French ExperienceTransplantation, 86
K. Ando, Y. Okada, M. Akiba, T. Kondo, T. Kawamura, M. Okumura, Fengshi Chen, H. Date, T. Shiraishi, A. Iwasaki, N. Yamasaki, T. Nagayasu, M. Chida, Y. Inoue, T. Hirai, K. Seyama, M. Mishima (2016)
Lung Transplantation for Lymphangioleiomyomatosis in JapanPLoS ONE, 11
T. Ito, M. Suno, K. Sakamoto, Y. Yoshizaki, K. Yamamoto, R. Nakanishi, Y. Hirano, M. Irie, T. Kurosaki, S. Otani, M. Yamane, S. Sugimoto, K. Miyoshi, T. Oto (2016)
Therapeutic Effect of Sirolimus for Lymphangioleiomyomatosis Remaining in the Abdominopelvic Region After Lung Transplantation: A Case Report.Transplantation proceedings, 48 1
T. Pechet, B. Meyers, T. Guthrie, R. Battafarano, E. Trulock, J. Cooper, G. Patterson (2001)
Lung transplantation for lymphangioleiomyomatosis.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 23 3
J. Munson, J. Christie, S. Halpern (2011)
The societal impact of single versus bilateral lung transplantation for chronic obstructive pulmonary disease.American journal of respiratory and critical care medicine, 184 11
A. Taveira-DaSilva, Olanda Hathaway, M. Stylianou, J. Moss (2011)
Changes in lung function and chylous effusions in patients with lymphangioleiomyomatosis treated with sirolimus.Annals of internal medicine, 154 12
G Thabut, JD Christie, P Ravaud, Y Castier (2009)
Annals of internal medicine article survival after bilateral versus single-lung transplantation forAnn Intern Med, 151
J. Groetzner, F. Kur, F. Spelsberg, J. Behr, L. Frey, I. Bittmann, M. Vogeser, P. Ueberfuhr, B. Meiser, R. Hatz, B. Reichart (2004)
Airway anastomosis complications in de novo lung transplantation with sirolimus-based immunosuppression.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 23 5
C. Benden, F. Rea, J. Behr, P. Corris, M. Reynaud‐Gaubert, M. Stern, R. Speich, A. Boehler (2009)
Lung transplantation for lymphangioleiomyomatosis: the European experience.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 28 1
M. Sato, Y. Okada, T. Oto, M. Minami, T. Shiraishi, T. Nagayasu, I. Yoshino, M. Chida, M. Okumura, H. Date, S. Miyoshi, T. Kondo, The Transplantation (2014)
Registry of the Japanese Society of Lung and Heart–Lung Transplantation: official Japanese lung transplantation report, 2014General Thoracic and Cardiovascular Surgery, 62
G. Thabut, J. Christie, P. Ravaud, Y. Castier, O. Brugière, M. Fournier, H. Mal, G. Lesèche, R. Porcher (2008)
Survival after bilateral versus single lung transplantation for patients with chronic obstructive pulmonary disease: a retrospective analysis of registry dataThe Lancet, 371
Purpose Lung transplantation is accepted as an effective modality for patients with end-stage pulmonary lymphangioleio- myomatosis (LAM). Generally, bilateral lung transplantation is preferred to single lung transplantation (SLT) for LAM because of native lung-related complications, such as pneumothorax and chylothorax. It remains controversial whether SLT is a suitable surgical option for LAM. The objective of this study was to evaluate the morbidity, mortality and outcome after SLT for LAM in a lung transplant center in Japan. Methods We reviewed the records of 29 patients who underwent SLT for LAM in our hospital between March, 2000 and November, 2017. The data collected included the pre-transplant demographics of recipients, surgical characteristics, com- plications, morbidity, mortality and survival after SLT for LAM. Results The most common complication after SLT for LAM was contralateral pneumothorax (n = 7; 24.1%). Six of these recipients were treated successfully with chest-tube placement and none required surgery for the pneumothorax. The second- most common complication was chylous pleural effusion (n = 6; 20.7%) and these recipients were all successfully treated by pleurodesis. The 5-year survival rate after SLT for LAM was 79.5%. Conclusion LAM-related complications after SLT for this disease can be managed. SLT is a treatment
Surgery Today – Springer Journals
Published: May 28, 2018
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.